1. Home
  2. POAI vs PPBT Comparison

POAI vs PPBT Comparison

Compare POAI & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • PPBT
  • Stock Information
  • Founded
  • POAI 2002
  • PPBT 2010
  • Country
  • POAI United States
  • PPBT Israel
  • Employees
  • POAI N/A
  • PPBT N/A
  • Industry
  • POAI Industrial Specialties
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • POAI Health Care
  • PPBT Health Care
  • Exchange
  • POAI Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • POAI 8.5M
  • PPBT 8.7M
  • IPO Year
  • POAI N/A
  • PPBT N/A
  • Fundamental
  • Price
  • POAI $1.51
  • PPBT $3.30
  • Analyst Decision
  • POAI Hold
  • PPBT Strong Buy
  • Analyst Count
  • POAI 1
  • PPBT 2
  • Target Price
  • POAI N/A
  • PPBT $126.50
  • AVG Volume (30 Days)
  • POAI 3.0M
  • PPBT 41.9K
  • Earning Date
  • POAI 03-27-2025
  • PPBT 03-04-2025
  • Dividend Yield
  • POAI N/A
  • PPBT N/A
  • EPS Growth
  • POAI N/A
  • PPBT N/A
  • EPS
  • POAI N/A
  • PPBT N/A
  • Revenue
  • POAI $1,484,223.00
  • PPBT N/A
  • Revenue This Year
  • POAI N/A
  • PPBT N/A
  • Revenue Next Year
  • POAI $569.48
  • PPBT N/A
  • P/E Ratio
  • POAI N/A
  • PPBT N/A
  • Revenue Growth
  • POAI N/A
  • PPBT N/A
  • 52 Week Low
  • POAI $0.55
  • PPBT $2.00
  • 52 Week High
  • POAI $3.76
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • POAI 59.10
  • PPBT 42.26
  • Support Level
  • POAI $1.36
  • PPBT $3.06
  • Resistance Level
  • POAI $1.64
  • PPBT $3.33
  • Average True Range (ATR)
  • POAI 0.23
  • PPBT 0.25
  • MACD
  • POAI -0.01
  • PPBT -0.03
  • Stochastic Oscillator
  • POAI 28.93
  • PPBT 29.63

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: